Abstract
In this report are used two data sets involving the main antidiabetic enzyme targets α-amylase and α-glucosidase. The prediction of α-amylase and α-glucosidase inhibitory activity as antidiabetic is carried out using LDA and classification trees (CT). A large data set of 640 compounds for α-amylase and 1546 compounds in the case of α-glucosidase are selected to develop the tree model. In the case of CT-J48 have the better classification model performances for both targets with values above 80%–90% for the training and prediction sets, correspondingly. The best model shows an accuracy higher than 95% for training set; the model was also validated using 10-fold cross-validation procedure and through a test set achieving accuracy values of 85.32% and 86.80%, correspondingly. Additionally, the obtained model is compared with other approaches previously published in the international literature showing better results. Finally, we can say that the present results provided a double-target approach for increasing the estimation of antidiabetic chemicals identification aimed by double-way workflow in virtual screening pipelines.
| Original language | English |
|---|---|
| Pages (from-to) | 1414-1421 |
| Number of pages | 8 |
| Journal | Chemical Biology and Drug Design |
| Volume | 94 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 John Wiley & Sons A/S
Keywords
- antidiabetic agents
- decision trees
- linear discriminant analysis
- QSAR
Fingerprint
Dive into the research topics of 'Beyond model interpretability using LDA and decision trees for α-amylase and α-glucosidase inhibitor classification studies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver